GL1X · GenesisL1 explorer

MolNFT v1 · #77231 · protein

CDK2 in complex with inhibitor L3-3

3R8M · Cyclin-dependent kinase 2: “CDK2 in complex with inhibitor L3-3”. X-ray diffraction, 2 ligands (Z19, PO4), 1 pocket (best druggability 0.75). MolNFT v1 #77231 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3R8M
Type
protein
Length
286 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
Z19, PO4
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein28631% helix, 16% strandP24941

Ligands and binding sites

  • Z19 · 1H-indazole-3-carbohydrazide · ligand · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15900.750.8268PO4, Z19

Compared structures

  • 3R8M · CDK2 in complex with inhibitor L3-3 · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.